• Liquid Wind

  Participated · Series B · Oct 2022

  Liquid Wind is a Gothenburg-headquartered developer of eFuel production plants designed to supply carbon-neutral eMethanol to shipping, aviation and chemical customers. Its facilities pair renewable-powered electrolysis with captured biogenic CO₂ to create eMethanol, enabling significant CO₂ emission reductions; the planned Örnsköldsvik plant will combine 150,000 tons of CO₂ with green hydrogen to deliver 100,000 tons of eMethanol and avoid 200,000 tons of CO₂e annually. The company counts roughly 70 employees and is working toward a pipeline of 10 projects by 2027 across Sweden, Denmark and Finland. Liquid Wind’s investor base includes industrial and strategic backers such as Alfa Laval, Carbon Clean, Elyse Energy, HYCAP, Samsung Ventures, Siemens Energy, Topsoe and Uniper. The firm integrates its eFuel plants with existing bio-powered combined heat and power (CHP) stations to maximize efficiency and circularity. Recent non-dilutive financing, including a €3.6 million grant from the Swedish Energy Agency, is helping fund pre-engineering of its first full-scale facility. This support underscores the company’s alignment with national and EU green-transition programs and strengthens its appeal to future commercial investors and offtakers.

• IGM Biosciences

  Participated · Series C · Jul 2019

  IGM Biosciences, based in Mountain View, Calif., focuses on creating and developing engineered IgM antibodies for the treatment of cancer patients. Founded in 2010, the company has built a proprietary IgM technology platform intended to deliver advantages over IgG antibodies for certain clinical indications. Its lead program is a CD20 x CD3 bispecific antibody, which is expected to enter the clinic later this year. IGM intends to use new funds to advance its IgM platform technology and its proprietary oncology pipeline. The company is led by CEO Fred Schwarzer. It recently closed a significant Series C financing to support these development plans.

• Faradion

  Participated · Series B · Jan 2017

  Faradion develops low-cost battery materials based on sodium-ion (Na-ion) chemistry tailored to both energy and power applications. Its core products and processes target stationary storage (on- and off-grid) and electric vehicle markets. The company is led by CEO Francis Massin and has filed more than 10 patent applications covering its materials and processing methods. Faradion intends to commercialize its Na-ion technology and scale prototype production. To support those plans it raised £3.2m in a Series B funding round. The funding is earmarked for large-scale prototype production and commercialization efforts.

No current team members are available.